Evidence map›Paper›PMID 37492926›Full record

ArticleThe EMBO journal2023

microRNAs slow translating ribosomes to prevent protein misfolding in eukaryotes.

Hiroaki Sako, Mohieldin Youssef, Olga Elisseeva, Takayuki Akimoto, Katsuhiko Suzuki, Takashi Ushida, Tadashi Yamamoto

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hiroaki SakoCell Signal Unit, Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan.ORCID 0000-0002-5812-655X
Mohieldin YoussefCell Signal Unit, Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan.ORCID 0000-0002-4657-0768
Olga ElisseevaCell Signal Unit, Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan.
Takayuki AkimotoFaculty of Sport Sciences, Waseda University, Saitama, Japan.
Katsuhiko SuzukiFaculty of Sport Sciences, Waseda University, Saitama, Japan.ORCID 0000-0002-6572-5809
Takashi UshidaDepartment of Mechanical Engineering, The University of Tokyo, Tokyo, Japan.
Tadashi YamamotoCell Signal Unit, Okinawa Institute of Science and Technology Graduate University (OIST), Okinawa, Japan.ORCID 0000-0002-5938-9378
Okinawa Institute of Science and Technology Graduate University · JPWaseda University · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Slower translation rates reduce protein misfolding. Such reductions in speed can be mediated by the presence of non-optimal codons, which allow time for proper folding to occur. Although this phenomenon is conserved from bacteria to humans, it is not known whether there are additional eukaryote-specific mechanisms which act in the same way. MicroRNAs (miRNAs), not present in prokaryotes, target both coding sequences (CDS) and 3' untranslated regions (UTR). Given their low suppressive efficiency, it has been unclear why miRNAs are equally likely to bind to a CDS. Here, we show that miRNAs transiently stall translating ribosomes, preventing protein misfolding with little negative effect on protein abundance. We first analyzed ribosome profiles and miRNA binding sites to examine whether miRNAs stall ribosomes. Furthermore, either global or specific miRNA deficiency accelerated ribosomes and induced aggregation of a misfolding-prone polypeptide reporter. These defects were rescued by slowing ribosomes using non-cleaving shRNAs as miRNA mimics. We finally show that proinsulin misfolding, associated with type II diabetes, was resolved by non-cleaving shRNAs. Our findings provide a eukaryote-specific mechanism of co-translational protein folding and a previously unknown mechanism of action to target protein misfolding diseases.

Indexed as

Diabetes Mellitus, Type 2MicroRNAsEukaryotaHumansProtein BiosynthesisProteinsRibosomesRNA, MessengerMicroRNAsProteinsRNA, MessengermiRNAmisfoldingtranslational pause

Identifiers

PMID37492926
PMCPMC10505912
OpenAlexW4385263883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.